<DOC>
	<DOCNO>NCT00771394</DOCNO>
	<brief_summary>To evaluate efficacy safety solifenacin succinate add-on therapy overactive bladder ( OAB ) symptom men treat benign prostatic hyperplasia ( BPH ) tamsulosin hydrochloride least 6 week</brief_summary>
	<brief_title>Solifenacin Add-on Therapy Overactive Bladder Symptoms Men Treated Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>Study drug administer 14 week total , include 2-week run-in period ( single blind ) 12-week treatment period ( double blind ) . After write informed consent , study drug run-in period orally administer daily breakfast two week subject fulfill inclusion exclusion criterion . Then , subject randomize orally treat study drug treatment period daily breakfast 12 week</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Patients benign prostatic hypertrophy treat tamsulosin least 6 week Patients urgency episode frequent micturition Written inform consent obtain UroflowmetryQ max ≥ 5 mL/sec , Post Void Residual Volume &lt; 50 mL Patients suspect symptoms OAB whose onset transient ( druginduced , psychogenic , etc . ) Patients obvious stress urinary incontinence Patients complication past history bladder tumor Patients urethral stricture bladder neck stenosis Patients history surgery cause damage pelvic plexus Patients history hypersensitivity α receptor blocker , a/b receptor blocker , anticholinergic drug Patients orthostatic hypotension , ulcerative colitis , hyperthyroidism , dementia cognitive dysfunction , Parkinson 's disease , cerebrovascular disorder</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Vesicare</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>Tamsulosin</keyword>
	<keyword>Overactive Bladder</keyword>
	<keyword>BPH</keyword>
</DOC>